Evogene Ltd. (EVGN)
NASDAQ: EVGN · Real-Time Price · USD
0.6190
+0.0093 (1.53%)
At close: Jun 5, 2026, 4:00 PM EDT
0.5804
-0.0386 (-6.24%)
After-hours: Jun 5, 2026, 7:25 PM EDT
Evogene Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 8.51 | 12.96 | 15.3 | 20.77 | 28.98 | 32.33 |
Short-Term Investments | 4.54 | - | - | 10.29 | 6.38 | 21.54 |
Cash & Short-Term Investments | 13.05 | 12.96 | 15.3 | 31.06 | 35.36 | 53.87 |
Cash Growth | 32.54% | -15.33% | -50.74% | -12.14% | -34.37% | 11.69% |
Accounts Receivable | 0.29 | 0.32 | 1.09 | 0.36 | 0.35 | 0.28 |
Other Receivables | 1.42 | 1.57 | 2.06 | 2.97 | 1.48 | 2.65 |
Total Trade Receivables | 1.7 | 1.88 | 3.16 | 3.33 | 1.83 | 2.93 |
Inventory | 0.18 | 0.21 | 1.82 | 0.08 | 0.57 | 0.09 |
Other Current Assets | 0.03 | 0.58 | 1.31 | - | - | - |
Total Current Assets | 14.96 | 15.63 | 21.59 | 34.47 | 37.75 | 56.89 |
Net Property, Plant & Equipment | 2.41 | 2.64 | 4.25 | 3.44 | 4.07 | 4.18 |
Other Intangible Assets | - | - | 12.2 | 13.17 | 14.14 | 15.21 |
Long-Term Investments | - | 0.04 | 0.08 | - | - | - |
Other Long-Term Assets | 0.58 | 1.74 | 1.75 | 0.03 | 0.17 | 0.03 |
Total Assets | 17.95 | 20.05 | 39.86 | 51.1 | 56.13 | 76.3 |
Accounts Payable | 0.46 | 0.64 | 1.23 | 1.79 | 1.04 | 1.46 |
Accrued Expenses | 0.92 | 0.86 | 1.87 | 2.54 | 1.99 | 2.66 |
Current Portion of Leases | 0.65 | 0.72 | 0.59 | 0.85 | 0.88 | 0.97 |
Unearned Revenue | 0.02 | 0.02 | 0.36 | 0.36 | 0.02 | 0.18 |
Other Current Liabilities | 3.3 | 1.21 | 14.65 | 1.41 | 1.7 | 1.61 |
Total Current Liabilities | 5.36 | 3.44 | 18.7 | 6.94 | 5.63 | 6.88 |
Long-Term Leases | 1.38 | 1.48 | 1.91 | 0.29 | 0.93 | 1.7 |
Other Long-Term Liabilities | 3.22 | 3.15 | 4.42 | 15.19 | 14.78 | 4.31 |
Total Long-Term Liabilities | 4.59 | 4.63 | 6.33 | 15.47 | 15.71 | 6 |
Total Liabilities | 9.96 | 8.07 | 25.03 | 22.42 | 21.34 | 12.88 |
Common Stock | 0.71 | 0.49 | 0.36 | 0.29 | 0.24 | 0.23 |
Additional Paid-in Capital | 285.17 | 281.99 | 272.26 | 269.35 | 261.4 | 260.49 |
Retained Earnings | -288.43 | -282.56 | -274.07 | -257.59 | -233.71 | -207.07 |
Total Common Shareholders' Equity | -2.55 | -0.08 | -1.45 | 12.05 | 27.93 | 53.65 |
Minority Interest | 10.54 | 12.06 | 16.29 | 16.63 | 6.86 | 9.77 |
Shareholders' Equity | 7.99 | 11.98 | 14.84 | 28.69 | 34.79 | 63.42 |
Total Liabilities & Equity | 17.95 | 20.05 | 39.86 | 51.1 | 56.13 | 76.3 |
Total Debt | 2.03 | 2.2 | 2.5 | 1.14 | 1.82 | 2.67 |
Net Cash (Debt) | 11.02 | 10.76 | 12.8 | 29.93 | 33.54 | 51.2 |
Net Cash Growth | 2.46% | -15.94% | -57.23% | -10.78% | -34.49% | 11.81% |
Net Cash Per Share | 1.28 | 1.37 | 2.25 | 6.52 | 8.10 | 12.66 |
Book Value | -2.55 | -0.08 | -1.45 | 12.05 | 27.93 | 53.65 |
Book Value Per Share | -0.30 | -0.01 | -0.25 | 2.63 | 6.74 | 13.27 |
Tangible Book Value | -2.55 | -0.08 | -13.65 | -1.12 | 13.79 | 38.45 |
Tangible Book Value Per Share | -0.30 | -0.01 | -2.40 | -0.24 | 3.33 | 9.51 |